Delivery Order SPE2DB20D1109-SPE2DB25FP61C
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,968.86 firm fixed-price delivery order is for the supply of 4564803696 units of Levorphanol 2 mg tablets, with a period of performance through May 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,427.54, is for the delivery of 4565295467 levorphanol 2 mg tablets in 100-count bottles. The contract has an ultimate completion date of July 31, 2024 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,513.46, is for the delivery of Levorphanol Tablets 2mg. It is a firm fixed-price delivery order contract with a completion date of December 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,557.66 firm fixed-price contract is for the delivery of Levorphanol Tablets 2mg, a specialty medication, with a performance period through May 17, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levorphanol 2 mg tablets, a medication used for pain management. The contract has a ceiling value of $3,969.02 and a completion date of February 5, 2025. It is a firm-fixed-price contract, meaning the price will not change regardless of the contractor's actual costs. The contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,270.19 firm fixed-price delivery order is for LEVORPHANOL TABS 2MG, with a period of performance through March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of 4564990933 - LEVORPHANOL TABS 2MG. The $9,911.41 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has an ultimate completion date of June 26, 2024 and does not have a set-aside designation. Amerisourcebergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levorphanol Tablets 2mg, a prescription medication, with a ceiling value of $1,756.73 and a period of performance through May 21, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, identified as SPE2DB20D1109 and SPE2DB25FN97A, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,568,073,816 tablets of the pharmaceutical drug Levorphanol 2 mg, with a ceiling value of $3,969.02 and a performance period through April 30, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP61CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Levorphanol 2 mg tablets (100-count) with a firm fixed price ceiling value of $1,402.57. The contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance is located at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order for the opioid analgesic Levorphanol exemplifies the company's role in fulfilling pharmaceutical supply needs for defense healthcare programs. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements, as demonstrated through its extensive portfolio of competitively awarded contracts covering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/20/25 |